のれん償却額 - 医薬品開発支援、契約負債、法人税等合計他2件
- 【期間】
| 年度 | のれん償却額 - 医薬品開発支援 | 契約負債 | 法人税等合計 | 投資有価証券 | 受取手形 |
|---|
| 2008/03 | - | | - | | 14.7億 | | 2.08億 | | 156百万 | |
| 2009/03 | - | | - | | 14.7億 | +0.1% | 1.98億 | -5% | 166百万 | +6.4% |
| 2010/03 | - | | - | | 13.9億 | -5.5% | 2.24億 | +13.1% | 98百万 | -40.8% |
| 2011/03 | - | | - | | 15.3億 | +10.1% | 2.33億 | +4.2% | 69百万 | -30.2% |
| 2012/03 | - | | - | | 15.1億 | -1.2% | 17.5億 | +651.8% | 85百万 | +23.9% |
| 2013/03 | 75百万 | | - | | 13.5億 | -10.8% | 10.7億 | -38.9% | 77百万 | -9.7% |
| 2014/03 | 73百万 | -1.6% | - | | 17億 | +25.8% | 9.66億 | -9.8% | - | |
| 2015/03 | 12百万 | -83.3% | - | | 26.1億 | +53.5% | 15.8億 | +63.2% | - | |
| 2016/03 | - | | - | | 14.9億 | -43% | 22.1億 | +40.3% | - | |
| 2017/03 | - | | - | | 13.9億 | -6.5% | 33.3億 | +50.5% | - | |
| 2018/03 | - | | - | | 12.9億 | -6.8% | 53.1億 | +59.6% | - | |
| 2019/03 | - | | - | | 14.2億 | +9.5% | 70.8億 | +33.2% | - | |
| 2020/06 | - | | - | | 12.9億 | -8.9% | 67.8億 | -4.2% | - | |
| 2021/06 | - | | - | | 17.5億 | +35.8% | 65億 | -4.1% | - | |
| 2022/06 | - | | 923百万 | | 16.5億 | -6.1% | 61.6億 | -5.2% | 653百万 | +750.5% |
| 2023/06 | - | | 750百万 | -18.8% | 8.85億 | -46.2% | 58.5億 | -5.1% | 625百万 | -4.4% |
